We are hiring! Manager – Communications & events – Apply now!

Job offers, News & Events

ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together … Read More

We are hiring! Project Manager – Apply now!

Job offers, News & Events

ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together … Read More

Axelys and the sector-based industrial research clusters are joining forces to boost innovation in Quebec for the benefit of research centers, businesses and society.

News & Events

Montréal, le 8 février 2023 – Axelys, la société de développement et de transfert des innovations issues de la recherche publique du Québec ainsi que les neuf (9) regroupements sectoriels de recherche industrielle (RSRI) composés de : CQDM, CQRDA, CRIAQ, CRIBIQ, CRITM, InnovÉÉ, MEDTEQ+, PRIMA Québec et Prompt, tous mandatés par le ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE), sont … Read More

CQDM and Defence Therapeutics fund the development of a new cancer vaccine platform

News & Events

Montreal, Quebec, February 2, 2023 – In celebration of World Cancer Day, CQDM is proud to announce the launch of a collaborative research project between Université de Montréal (UdeM), the Lady Davis Institute of the Jewish General Hospital and Defence Therapeutics, a Quebec-based biotechnology company specialized in the development of next-generation vaccines. The funding of this study, totalling $1,359,851, was … Read More

CQDM funds a collaborative research project between the RI-MUHC and Divocco AI to develop an artificial intelligence-driven technology that improves regional anesthesia

News & Events

Montreal, Quebec, December 8, 2022 – CQDM is pleased to announce the funding of a research study carried out at the Research Institute of the McGill University Health Centre (RI-MUHC) in collaboration with Divocco AI, a Montreal-based company focusing on perioperative care improvement using artificial intelligence (AI)-derived medical devices. The funding, totalling $1,057,502, was made possible by a grant of … Read More

CQDM Funds a Project Aiming to Elucidate the Effets of Psilocybin on Neuronal Circuits in Order to Treat Depression

News & Events

Montreal (Quebec), November 24, 2022 – CQDM is proud to announce the funding of a research project led by Rosemary Bagot, Associate Professor at the Department of Psychology at McGill University. The project will be funded in collaboration with McGill University, Cubed Biotech Inc. (“Cubed Biotech”), as well as McGill University’s Healthy Brains, Healthy Lives (HBHL) initiative and the Irving … Read More

ADRIQ 2022 Award – Warmest congratulations to Steven LaPlante of INRS and NMX Research and Solutions, winners of the Industrial Sectoral Research Group Award (RSRI) presented by CQDM!

News & Events

Montréal, November 17, 2022 – During the 32nd ADRIQ 2022 Innovation Awards Gala, Steven LaPlante, a researcher at INRS – Armand-Frappier Santé Biotechnologie Research Centre, and NMX Research and Solutions, a Québec contract research firm, received one of the Industrial Sectoral Research Group Awards (RSRI). Presented by CQDM, this recognition aims to highlight the role of collaborative research as a lever … Read More

The Canadian Cancer Society, CQDM, the Cole Foundation and Oncopole grant close to $8.5 million to four researchers in Quebec to support pediatric cancer research

News & Events

MONTREAL, November 2, 2022 ─ The Canadian Cancer Society (CCS), CQDM, the Cole Foundation and Oncopole – pôle cancer du FRQS announced, today, grants of $8,485,132 to finance four research projects in Quebec, as part of the Pediatric Cancer Research Initiative. This funding, which will take place over three years, is part of a unique partnership created to support pediatric cancer … Read More

JOB OFFER – DIRECTOR SCIENTIFIC AFFAIRS

Job offers, News & Events

ABOUT CQDM Since its creation, CQDM has raised nearly $190 million to fund the development of approximately 130 drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and effective drugs. We bring together world-leading … Read More